Molecular hydrogen is associated with immunophenotypic modulation and changes in T-cell exhaustion markers in refractory primary Sjögren’s syndrome-associated interstitial lung disease: A case report

Wei-Hung Hsu, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu · 2026

Read Molecular hydrogen is associated with immunophenotypic modulation and changes in T-cell exhaustion markers in refractory primary Sjögren’s syndrome-associated interstitial lung disease: A case report by Wei-Hung Hsu, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241678.txt.

Description

Wei-Hung Hsu and co-authors report a 2026 case of hydrogen therapy in stubborn lung disease linked to Sjögren syndrome. A 72-year-old woman had worsening breathlessness and lung scarring despite steroids, standard immune drugs, and a biologic therapy. She began taking oral molecular hydrogen capsules as an add-on.

Follow-up testing showed better gas exchange and stable scans, with no further scarring advance. A key antibody level fell. Blood cell profiling showed immune patterns shifting toward those of healthy people, including changes in T cell exhaustion markers. No side effects appeared. The authors urge caution, since earlier treatments might explain part of the change. They call for formal trials of hydrogen as an add-on therapy.

Catalog record

CREATORWei-Hung Hsu, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13241678

Browse the full library · About the Tower of Babel